Australia to trial immunoglobulin treatment for COVID-19

The therapy will be made from plasma donated by recovered patients, researchers say

Patients who have recovered from COVID-19 will be urged to donate plasma for a landmark trial in a bid to find an effective antibody-based treatment against the virus.